T1	DISO 584 589	CPRCm
T2	CHEM 55 64	nivolumab
#1	AnnotatorNotes T2	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T3	PROC 67 74	placebo
#2	AnnotatorNotes T3	C0032042; Placebos; Therapeutic or Preventive Procedure
T4	CHEM 94 103	docetaxel
#3	AnnotatorNotes T4	C0246415; docetaxel; Organic Chemical · Pharmacologic Substance
T5	DISO 120 138	cáncer de próstata
#4	AnnotatorNotes T5	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T6	DISO 1085 1090	CPRCm
T7	PROC 217 246	evaluación del ensayo clínico
T8	CHEM 250 259	nivoluMAb
#5	AnnotatorNotes T8	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T9	PROC 286 332	Estudio de fase III, aleatorizado, doble ciego
T10	CHEM 336 345	nivolumab
#6	AnnotatorNotes T10	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T11	PROC 348 355	placebo
#7	AnnotatorNotes T11	C0032042; Placebos; Therapeutic or Preventive Procedure
T12	CHEM 375 384	docetaxel
#8	AnnotatorNotes T12	C0246415; docetaxel; Organic Chemical · Pharmacologic Substance
T13	DISO 401 419	cáncer de próstata
#9	AnnotatorNotes T13	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T14	DISO 447 458	metastásico
#10	AnnotatorNotes T14	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T15	DISO 481 499	Cáncer de próstata
#11	AnnotatorNotes T15	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T16	DISO 525 543	Cáncer de próstata
#12	AnnotatorNotes T16	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T17	DISO 571 582	metastásico
#13	AnnotatorNotes T17	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T18	DISO 648 677	adenocarcinoma de la próstata
#14	AnnotatorNotes T18	C0007112; Adenocarcinoma of prostate; Neoplastic Process
T19	DISO 696 706	enfermedad
#15	AnnotatorNotes T19	C0012634; Disease; Disease or Syndrome
T20	DISO 792 810	cáncer de próstata
#16	AnnotatorNotes T20	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T21	CHEM 900 949	análogo de la hormona liberadora de gonadotropina
#17	AnnotatorNotes T21	C1518041; Luteinizing Hormone-releasing Hormone Agonist; Pharmacologic Substance
T22	CHEM 983 987	GnRH
#18	AnnotatorNotes T22	C0023610; gonadorelin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T23	PROC 995 1017	orquiectomía bilateral
#19	AnnotatorNotes T23	C0007347; Male Castration; Therapeutic or Preventive Procedure
T24	PROC 1056 1069	quimioterapia
#20	AnnotatorNotes T24	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T25	PROC 1138 1163	manipulaciones hormonales
T26	DISO 1209 1218	tumorales
#21	AnnotatorNotes T26	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T27	PROC 1226 1233	biopsia
#22	AnnotatorNotes T27	C0005558; Biopsy; Diagnostic Procedure
T28	DISO 1327 1353	lesión tumoral metastásica
T29	DISO 1363 1386	lesión tumoral primaria
T30	DISO 1472 1493	metástasis cerebrales
#23	AnnotatorNotes T30	C0220650; Metastatic malignant neoplasm to brain; Neoplastic Process | C0555278; Cerebral metastasis; Neoplastic Process
T31	DISO 1504 1521	Neoplasia maligna
#24	AnnotatorNotes T31	C0006826; Malignant Neoplasms; Neoplastic Process
T32	DISO 1570 1576	cáncer
#25	AnnotatorNotes T32	C0006826; Malignant Neoplasms; Neoplastic Process
T33	DISO 1653 1679	enfermedad autoinmunitaria
#26	AnnotatorNotes T33	C0004364; Autoimmune Diseases; Disease or Syndrome
T34	DISO 1732 1740	afección
#27	AnnotatorNotes T34	C0221423; Illness (finding); Sign or Symptom
T35	PROC 1754 1797	tratamiento sistémico con corticoesteroides
T36	CHEM 1780 1797	corticoesteroides
#28	AnnotatorNotes T36	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T37	CHEM 1834 1844	prednisona
#29	AnnotatorNotes T37	C0032952; prednisone; Hormone · Organic Chemical · Pharmacologic Substance
T38	CHEM 1863 1879	inmunosupresores
#30	AnnotatorNotes T38	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T39	PROC 1882 1893	Tratamiento
#31	AnnotatorNotes T39	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T40	CHEM 1908 1928	anticuerpo anti-PD-1
T41	CHEM 1930 1940	anti-PD-L1
T42	CHEM 1942 1952	anti-PD-L2
T43	CHEM 1955 1966	anti-CTLA-4
T44	CHEM 1977 1987	ipilimumab
#32	AnnotatorNotes T44	C1367202; ipilimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T45	CHEM 2010 2020	anticuerpo
#33	AnnotatorNotes T45	C0003241; Antibodies; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T46	CHEM 2023 2137	fármaco que actúe de manera específica sobre la coestimulación de linfocitos T o las vías de los puntos de control
#34	AnnotatorNotes T46	C3192215; Selective T Cell Costimulation Blocker; Pharmacologic Substance (?) | C4684977; Immune Checkpoint Inhibitors; Pharmacologic Substance (?)
T47	ANAT 2089 2101	linfocitos T
#35	AnnotatorNotes T47	C0039194; T-Lymphocyte; Cell
T48	PROC 2140 2151	Tratamiento
#36	AnnotatorNotes T48	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T49	CHEM 2163 2172	docetaxel
#37	AnnotatorNotes T49	C0246415; docetaxel; Organic Chemical · Pharmacologic Substance
T50	CHEM 2180 2209	medicamento quimioterapéutico
#38	AnnotatorNotes T50	C0003392; Antineoplastic Agents; Organic Chemical · Pharmacologic Substance
T51	DISO 2218 2236	cáncer de próstata
#39	AnnotatorNotes T51	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T52	DISO 2264 2275	metastásico
#40	AnnotatorNotes T52	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T53	ANAT 130 138	próstata
#41	AnnotatorNotes T53	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T54	PROC 155 165	castración
#42	AnnotatorNotes T54	C0007344; Castration; Therapeutic or Preventive Procedure
T55	ANAT 411 419	próstata
#43	AnnotatorNotes T55	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T56	PROC 436 446	castración
#44	AnnotatorNotes T56	C0007344; Castration; Therapeutic or Preventive Procedure
T57	ANAT 491 499	próstata
#45	AnnotatorNotes T57	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T58	ANAT 535 543	próstata
#46	AnnotatorNotes T58	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T59	PROC 560 570	castración
#47	AnnotatorNotes T59	C0007344; Castration; Therapeutic or Preventive Procedure
T60	ANAT 669 677	próstata
#48	AnnotatorNotes T60	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T61	ANAT 802 810	próstata
#49	AnnotatorNotes T61	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T62	PROC 880 883	TPA
#50	AnnotatorNotes T62	C0279492; Androgen Deprivation Therapy; Therapeutic or Preventive Procedure [tratamiento de privación de andrógenos]
T63	CHEM 1153 1163	hormonales
#51	AnnotatorNotes T63	C0019932; Hormones; Hormone
T64	ANAT 1200 1218	muestras tumorales
T65	PROC 1404 1413	irradiada
#52	AnnotatorNotes T65	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T66	ANAT 1483 1493	cerebrales
#53	AnnotatorNotes T66	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T67	PROC 2192 2209	quimioterapéutico
#54	AnnotatorNotes T67	C0870057; Chemotherapeutic Procedures; Therapeutic or Preventive Procedure
T68	ANAT 2228 2236	próstata
#55	AnnotatorNotes T68	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T69	PROC 2253 2263	castración
#56	AnnotatorNotes T69	C0007344; Castration; Therapeutic or Preventive Procedure
T70	Date 12 16	2019
T71	LIVB 108 115	hombres
#57	AnnotatorNotes T71	C0025266; Male population group; Population Group
T72	LIVB 389 396	hombres
#58	AnnotatorNotes T72	C0025266; Male population group; Population Group
T74	Duration 840 851	los 6 meses
T75	Date 884 892	en curso
T76	Neg_cue 1038 1040	no
T78	Date 1234 1242	reciente
T79	Neg_cue 1265 1267	no
T80	Duration 1268 1280	mas de 1 año
T81	Neg_cue 1391 1393	no
T82	Duration 1539 1560	los 3 años anteriores
T83	Neg_cue 1562 1569	excepto
T84	Spec_cue 1699 1707	presunta
T85	Dose 1799 1805	>10 mg
T86	Frequency 1806 1813	diarios
T73	PHYS 2071 2101	coestimulación de linfocitos T
#59	AnnotatorNotes T73	C1622572; T cell costimulation; Cell Function
T77	LIVB 1020 1033	Participantes
#60	AnnotatorNotes T77	C4554048; Study Participant; Population Group
T87	LIVB 1454 1467	Participantes
#61	AnnotatorNotes T87	C4554048; Study Participant; Population Group
T88	LIVB 1631 1644	Participantes
#62	AnnotatorNotes T88	C4554048; Study Participant; Population Group
T89	LIVB 1710 1723	Participantes
#63	AnnotatorNotes T89	C4554048; Study Participant; Population Group
T90	PROC 736 752	estado funcional
#64	AnnotatorNotes T90	C4525818; Clinical Performance Status; Health Care Activity | C3694602; functional status of patient; Therapeutic or Preventive Procedure
T91	PROC 619 643	Confirmación histológica
#65	AnnotatorNotes T91	C0344441; Histology Procedure; Laboratory Procedure
A1	Assertion T24 Negated
A2	Assertion T80 Negated
A3	Assertion T65 Negated
A4	Assertion T32 Negated
A5	Assertion T33 Speculated
A6	Status T23 History_of
A7	Status T24 History_of
A8	Status T25 History_of
A9	Status T27 History_of
A10	Status T65 History_of
A11	Status T31 History_of
A12	Status T32 History_of
A13	Status T33 History_of
A14	Status T39 History_of
A15	Status T40 History_of
A16	Status T41 History_of
A17	Status T42 History_of
A18	Status T43 History_of
A19	Status T44 History_of
A20	Status T45 History_of
A21	Status T46 History_of
A22	Status T48 History_of
A23	Status T49 History_of
A24	Status T50 History_of
#66	AnnotatorNotes T9	C0282461; Phase 3 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity
#67	AnnotatorNotes T1	C4721208; Metastatic castration-resistant prostate cancer; Neoplastic Process 
#68	AnnotatorNotes T64	C0475358; Tumor tissue sample; Tissue
#69	AnnotatorNotes T6	C4721208; Metastatic castration-resistant prostate cancer; Neoplastic Process
#70	AnnotatorNotes T35	C4053960; Systemic Corticosteroid Therapy; Therapeutic or Preventive Procedure 
#71	AnnotatorNotes T40	C4289971; Anti-PD-L1 Monoclonal Antibody; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
#72	AnnotatorNotes T41	C4289971; Anti-PD-L1 Monoclonal Antibody; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
#73	AnnotatorNotes T78	C0332185; Recent; Temporal Concept
#74	AnnotatorNotes T43	C4289973; Anti-CTLA-4 Monoclonal Antibody; Amino Acid, Peptide, or Protein
T92	Quantifier_or_Qualifier 1108 1118	al menos 1
T93	Neg_cue 1125 1127	no
T94	Quantifier_or_Qualifier 1128 1136	más de 2
A25	Assertion T94 Negated
T95	Quantifier_or_Qualifier 1577 1595	localmente curable
A26	Assertion T95 Negated
R1	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T95	
R2	Negation Arg1:T83 Arg2:T32	
R3	Negation Arg1:T83 Arg2:T95	
T96	Observation 1608 1628	curado aparentemente
A27	Assertion T96 Negated
R4	Negation Arg1:T83 Arg2:T96	
R5	Negation Arg1:T76 Arg2:T24	
R6	Negation Arg1:T93 Arg2:T94	
R7	Negation Arg1:T79 Arg2:T80	
R8	Negation Arg1:T81 Arg2:T65	
R9	Speculation Arg1:T84 Arg2:T33	
R10	Combined_with Arg1:T2 Arg2:T4	
R11	Combined_with Arg1:T3 Arg2:T4	
R12	Experiences Arg1:T71 Arg2:T2	
R13	Experiences Arg1:T71 Arg2:T3	
R14	Experiences Arg1:T71 Arg2:T5	
R15	Location_of Arg1:T53 Arg2:T5	
R16	Experiences Arg1:T71 Arg2:T54	
T97	Observation 139 165	resistente a la castración
#75	AnnotatorNotes T97	C4329620; Castration Resistance; Finding
R17	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T97	
R18	Experiences Arg1:T71 Arg2:T97	
T98	Quantifier_or_Qualifier 166 174	avanzado
#76	AnnotatorNotes T98	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R20	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T98	
R21	Location_of Arg1:T55 Arg2:T13	
R22	Experiences Arg1:T71 Arg2:T8	
R23	Combined_with Arg1:T10 Arg2:T12	
R24	Combined_with Arg1:T11 Arg2:T12	
R25	Experiences Arg1:T72 Arg2:T10	
R26	Experiences Arg1:T72 Arg2:T11	
R27	Experiences Arg1:T72 Arg2:T13	
R28	Experiences Arg1:T72 Arg2:T56	
R29	Experiences Arg1:T72 Arg2:T14	
R30	Before Arg1:T13 Arg2:T14	
T99	Observation 420 446	resistente a la castración
#77	AnnotatorNotes T99	C4329620; Castration Resistance; Finding
R31	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T99	
R32	Location_of Arg1:T57 Arg2:T15	
R33	Location_of Arg1:T58 Arg2:T16	
T100	Observation 544 570	resistente a la castración
#78	AnnotatorNotes T100	C4329620; Castration Resistance; Finding
R34	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T100	
R35	Before Arg1:T16 Arg2:T17	
R36	Has_Quantifier_or_Qualifier Arg1:T1 Arg2:T100	
R37	Has_Quantifier_or_Qualifier Arg1:T1 Arg2:T17	
R38	Location_of Arg1:T58 Arg2:T1	
R41	Location_of Arg1:T60 Arg2:T18	
T101	Quantifier_or_Qualifier 710 719	estadio 4
R42	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T101	
R43	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T101	
T102	CONC 753 757	ECOG
#79	AnnotatorNotes T102	C1520224; ECOG performance status; Intellectual Product
R44	Used_for Arg1:T102 Arg2:T90	
T103	Quantifier_or_Qualifier 758 762	0 -1
R45	Has_Quantifier_or_Qualifier Arg1:T102 Arg2:T103	
T104	Observation 765 775	Progresión
#80	AnnotatorNotes T104	C1457868; Worse; Finding (?)
R46	Overlap Arg1:T104 Arg2:T74	
T105	PROC 868 877	selección
#81	AnnotatorNotes T105	C0242802; Patient Selection; Research Activity
R47	Before Arg1:T104 Arg2:T105	
R48	Location_of Arg1:T61 Arg2:T20	
R49	Before Arg1:T20 Arg2:T104	
R50	Overlap Arg1:T62 Arg2:T75	
R51	Used_for Arg1:T21 Arg2:T62	
R52	Experiences Arg1:T77 Arg2:T24	
R53	Experiences Arg1:T77 Arg2:T6	
R54	Used_for Arg1:T63 Arg2:T25	
R55	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T92	
R56	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T94	
T106	Quantifier_or_Qualifier 1164 1185	de segunda generación
R57	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T106	
R58	Experiences Arg1:T77 Arg2:T25	
#82	AnnotatorNotes T25	C0279025; Hormone Therapy; Therapeutic or Preventive Procedure
R59	Overlap Arg1:T27 Arg2:T78	
T107	ANAT 1200 1208	muestras
R60	Overlap Arg1:T107 Arg2:T80	
T108	CONC 1302 1311	inclusión
#84	AnnotatorNotes T108	C1512693; Inclusion; Qualitative Concept
R61	Before Arg1:T107 Arg2:T108	
#85	AnnotatorNotes T28	C1513183; Metastatic Lesion; Finding
R62	Experiences Arg1:T87 Arg2:T30	
R63	Location_of Arg1:T66 Arg2:T30	
T109	Quantifier_or_Qualifier 1494 1501	activas
#86	AnnotatorNotes T109	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R64	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T109	
T110	Quantifier_or_Qualifier 1522 1528	activa
#87	AnnotatorNotes T110	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R65	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T110	
R66	Overlap Arg1:T31 Arg2:T82	
R67	Before Arg1:T32 Arg2:T96	
R68	Experiences Arg1:T88 Arg2:T33	
T111	Quantifier_or_Qualifier 1680 1686	activa
#88	AnnotatorNotes T111	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R69	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T111	
R70	Experiences Arg1:T89 Arg2:T34	
R71	Experiences Arg1:T89 Arg2:T35	
R72	Used_for Arg1:T36 Arg2:T35	
R73	Has_Dose_or_Strength Arg1:T36 Arg2:T85	
R74	Has_Frequency Arg1:T36 Arg2:T86	
R75	Has_Frequency Arg1:T37 Arg2:T86	
R76	Has_Dose_or_Strength Arg1:T37 Arg2:T85	
T112	CONC 1820 1844	equivalente a prednisona
R77	Experiences Arg1:T89 Arg2:T38	
R78	Used_for Arg1:T40 Arg2:T39	
R79	Used_for Arg1:T41 Arg2:T39	
R80	Used_for Arg1:T42 Arg2:T39	
R81	Used_for Arg1:T43 Arg2:T39	
R82	Used_for Arg1:T44 Arg2:T39	
R83	Used_for Arg1:T45 Arg2:T39	
R84	Used_for Arg1:T46 Arg2:T39	
R86	Used_for Arg1:T49 Arg2:T48	
R87	Used_for Arg1:T50 Arg2:T48	
R88	Used_for Arg1:T50 Arg2:T67	
R89	Used_for Arg1:T49 Arg2:T67	
R90	Location_of Arg1:T68 Arg2:T51	
R91	Before Arg1:T51 Arg2:T52	
T113	Observation 2237 2263	resistente a la castración
#89	AnnotatorNotes T113	C4329620; Castration Resistance; Finding
R92	Has_Quantifier_or_Qualifier Arg1:T51 Arg2:T113	
T114	CONC 680 706	evidencia de la enfermedad
#90	AnnotatorNotes T114	C5554846; Clinical Evidence; Idea or Concept (?)
R96	Location_of Arg1:T60 Arg2:T19	
T115	Quantifier_or_Qualifier 1245 1255	de archivo
#83	AnnotatorNotes T115	C4724030; Archived; Functional Concept
R98	Has_Quantifier_or_Qualifier Arg1:T107 Arg2:T115	
#91	AnnotatorNotes T107	C2347026; Biospecimen; Body Substance
R99	Experiences Arg1:T72 Arg2:T99	
#92	AnnotatorNotes T75	C0521116; Current (present time); Temporal Concept
